Paper7828276
Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells.
Beketic-Oreskovic L and 1 other. Cancer Chemother Pharmacol, 1995. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Papers, record 7828276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7828276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Aphidicolin | Major topic |
| Cisplatin | Major topic |
| Laryngeal Neoplasms | Major topic |
| Cell Survival | |
| Cyclosporine | |
| Drug Resistance | |
| Humans | |
| Tumor Cells, Cultured | |
| Tumor Stem Cell Assay |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 692726 | Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. | Nature | 1978 | https://conductscience.org/library/papers/692726 | PubMed |
| 2 | 3465432 | Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60. | Cancer Res | 1986 | https://conductscience.org/library/papers/3465432 | PubMed |
| 3 | 1898714 | Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II). | Cancer Res | 1991 | https://conductscience.org/library/papers/1898714 | PubMed |
| 4 | 2572960 | Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. | Mol Pharmacol | 1989 | https://conductscience.org/library/papers/2572960 | PubMed |
| 5 | 8306334 | Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. | Cancer Res | 1994 | https://conductscience.org/library/papers/8306334 | PubMed |
| 6 | 1528326 | Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammineplatinum (II) or vincristine sulfate. | Neoplasma | 1992 | https://conductscience.org/library/papers/1528326 | PubMed |
| 7 | 4028003 | Effect of amphotericin B on Adriamycin transport in P388 cells. | Cancer Res | 1985 | https://conductscience.org/library/papers/4028003 | PubMed |
| 8 | 1715516 | Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. | Nature | 1991 | https://conductscience.org/library/papers/1715516 | PubMed |
| 9 | 1886148 | Phase I and clinical pharmacological evaluation of aphidicolin glycinate. | J Natl Cancer Inst | 1991 | https://conductscience.org/library/papers/1886148 | PubMed |
| 10 | 1403041 | Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1403041 | PubMed |
| 11 | 2208103 | Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. | Cancer Res | 1990 | https://conductscience.org/library/papers/2208103 | PubMed |
| 12 | 2659168 | Non-chemotherapeutic agents that potentiate chemotherapy efficacy. | Cancer Treat Rev | 1989 | https://conductscience.org/library/papers/2659168 | PubMed |
| 13 | 1655771 | Cyclosporin A blocks calcium-dependent pathways of gene activation. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1655771 | PubMed |
| 14 | 1900371 | A uv-sensitive Chinese hamster lung fibroblast cell line (V79/UC) with a possible defect in DNA polymerase activity is deficient in DNA repair. | Radiat Res | 1991 | https://conductscience.org/library/papers/1900371 | PubMed |
| 15 | 1901253 | Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro. | Carcinogenesis | 1991 | https://conductscience.org/library/papers/1901253 | PubMed |
| 16 | 1403040 | Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1403040 | PubMed |
| 17 | 7396898 | Amphotericin B (Fungizone R) enhancement of nitrogen mustard uptake by human tumor cells. | Biochem Biophys Res Commun | 1980 | https://conductscience.org/library/papers/7396898 | PubMed |
| 18 | 3144285 | Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. | Biochem Pharmacol | 1988 | https://conductscience.org/library/papers/3144285 | PubMed |
| 19 | 1503895 | Modulation of cis-diamminedichloroplatinum(II) resistance: a review. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1503895 | PubMed |
| 20 | 8420689 | Mechanisms of drug resistance in ovarian cancer. | Cancer | 1993 | https://conductscience.org/library/papers/8420689 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24009588 | Cell volume regulation in epithelial physiology and cancer. | Front Physiol | 2013 | https://conductscience.org/library/papers/24009588 | PubMed |
| 23219605 | Evidence for base excision repair processing of DNA interstrand crosslinks. | Mutat Res | 2013 | https://conductscience.org/library/papers/23219605 | PubMed |
| 19002791 | Drug resistance and DNA repair in leukaemia. | Cytotechnology | 1998 | https://conductscience.org/library/papers/19002791 | PubMed |
| 8956785 | Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8956785 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7828276
GET https://conductscience.org/api/papers/v1/7828276/references?page=2